颈部胸腺切除术对多发性内分泌腺瘤病1型患者甲状旁腺切除术的影响
基于TriNetX数据库的回顾性研究纳入434例多发性内分泌腺瘤病1型(MEN1)合并原发性甲状旁腺功能亢进患者,比较甲状旁腺切除术联合或不联合颈部胸腺切除术的结局。
要点
- MEN1患者甲状旁腺切除术联合颈部胸腺切除术可提高治愈率并降低持续性疾病风险。
- 联合胸腺切除术增加短暂性甲状旁腺功能减退风险,但不增加永久性甲状旁腺功能减退。
- 建议将颈部胸腺切除术作为MEN1患者甲状旁腺切除术的标准组成部分。
核心结论
- MEN1合并原发性甲状旁腺功能亢进患者行甲状旁腺切除术时联合颈部胸腺切除术与更高治愈率相关,且不显著增加永久性并发症。
- 颈部胸腺切除术应被视为MEN1患者甲状旁腺切除术的标准治疗组成部分。
研究设计与样本
- 纳入434例MEN1行甲状旁腺切除术患者,其中129例联合胸腺切除术,305例未联合。
主要发现
- 联合胸腺切除术使持续性疾病风险降低74%(相对风险0.26,95%CI 0.10-0.72)。
关键数值与推荐
- MEN1患者甲状旁腺切除术中推荐联合颈部胸腺切除术以提高治愈率并降低持续性疾病风险。
- 联合胸腺切除术虽增加短暂性甲状旁腺功能减退,但永久性甲状旁腺功能减退风险无显著增加。
临床怎么用
- 对于MEN1合并原发性甲状旁腺功能亢进患者,甲状旁腺切除术中应考虑常规联合颈部胸腺切除术。
- 术前应与患者沟通联合胸腺切除术可提高治愈率,但可能增加短暂性甲状旁腺功能减退的风险。
局限性
- 回顾性研究设计可能存在选择偏倚和混杂因素。
- 使用TriNetX数据库,数据来源和准确性受限于各机构记录。
- 未报告手术方式、胸腺切除范围等细节,可能影响结果解释。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cervical thymectomy is commonly performed during parathyroidectomy for primary hyperparathyroidism in multiple endocrine neoplasia type 1. Recently, there have been several single-institutional studies that have found no added benefit to the addition of thymectomy and question its impact on postoperative outcomes. We aimed to evaluate the outcomes of concomitant cervical thymectomy in multiple endocrine neoplasia type 1 patients undergoing parathyroidectomy for primary hyperparathyroidism using a large cohort of patients. METHODS: This retrospective study used the TriNetX research platform, a global collaborative network representing over 130 million patients. We identified 434 patients with multiple endocrine neoplasia type 1 who underwent parathyroidectomy with and without cervical thymectomy. Outcomes assessed between 129 cases of thymectomy and 305 controls without thymectomy include rates of reoperation, cure, persistent and recurrent disease, and transient and permanent hypoparathyroidism. RESULTS: Adding cervical thymectomy to parathyroidectomy was associated with higher cure rates (96.9% vs 88.2%; P = .004), demonstrating a 74% reduction in the risk of persistent disease (relative risk, 0.26; 95% confidence interval, 0.10-0.72) when compared with that of parathyroidectomy alone. While transient hypoparathyroidism rates rose with the addition of thymectomy (38.0% vs 24.3%; P= .017), there was no significant difference in the rate of permanent hypoparathyroidism (3.1% vs 1.6%; P = .328). CONCLUSION: Adding cervical thymectomy to parathyroidectomy during the surgical management of multiple endocrine neoplasia type 1 patients with primary hyperparathyroidism is associated with higher cure rates without a significant increase in permanent complications. Cervical thymectomy should, therefore, be considered a standard component of care for multiple endocrine neoplasia type 1 patients undergoing parathyroidectomy for primary hyperparathyroidism.
引用
- Bashumeel YY, Abdelmaksoud A, Omar M, et al. Impact of cervical thymectomy on multiple endocrine neoplasia type 1 patients undergoing parathyroidectomy for primary hyperparathyroidism. Surgery. 2026. PMID: 42140757. doi:10.1016/j.surg.2026.110261
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。